Abstract
Reverse rate-dependence, a lessening in Class III antiarrhythmic agent action potential duration (APD) prolongation as heart rate is increased, has been proposed to be related to an incomplete deactivation of the slow component (IKs) of the delayed rectifier K+ current (IK). The rate-dependent properties of block of IK by azimilide were compared to E-4031, which selectively blocks the rapid component (IKr) of IK, in guinea pig ventricular muscle. Azimilide prolonged APD in isolated papillary muscles in a concentration-dependent manner and to a greater degree than E-4031. Both agents prolonged APD less at fast than slow rates, consistent with a similar reverse rate-dependent effect. Isolation of azimilide block of IKs by subtraction of APD during E-4031 plus azimilide from E-4031 alone revealed rate-independent prolongation of APD. In voltage clamp experiments on single ventricular myocytes, activation of IKs was similar following 30 seconds of conditioning pulses of physiological duration (125 to 200 msec) with either a fast (cycle length 250 msec) or slow (cycle length 2000 msec) rate. The block of IKs by azimilide 3 microM was greater after a fast conditioning pulse train. Selective block of IKs prolongs APD in a rate-indepen...Continue Reading
References
Sep 11, 1991·Journal of Cardiovascular Pharmacology·E P BaskinJ J Lynch
Aug 1, 1991·Circulation Research·J R BalserD M Roden
Nov 1, 1991·The American Journal of Cardiology·C SchmittW Kübler
Feb 1, 1990·Circulation·L M Hondeghem, D J Snyders
Jul 1, 1990·The Journal of General Physiology·M C Sanguinetti, N K Jurkiewicz
Sep 1, 1990·The Journal of Physiology·A C Zygmunt, J Maylie
Apr 1, 1989·Circulation·K P AndersonP M Urie
Dec 1, 1987·Pflügers Archiv : European journal of physiology·H MatsuuraY Imoto
Aug 1, 1970·British Journal of Pharmacology·B N Singh, E M Vaughan Williams
Jan 1, 1980·Progress in Biophysics and Molecular Biology·M R Boyett, B R Jewell
Jan 1, 1981·The Journal of Physiology·D AttwellD A Eisner
Aug 1, 1995·Journal of Cardiovascular Pharmacology·B FerminiJ J Salata
Jul 15, 1994·Biochemical and Biophysical Research Communications·A E BuschJ Maylie
Jan 1, 1993·Circulation Research·N K Jurkiewicz, M C Sanguinetti
Citations
May 20, 1998·Biophysical Journal·T TzounopoulosJ P Adelman
Aug 10, 1999·European Journal of Pharmacology·Y XueK Hashimoto
Jun 22, 2000·Heart·J C HancoxJ V Jones
Nov 4, 2000·Expert Opinion on Investigational Drugs·S A Doggrell, L Brown
Dec 16, 2000·Expert Opinion on Investigational Drugs·S A Doggrell
Apr 16, 1998·The American Journal of Cardiology·R KaramA Moore
Apr 16, 1998·The American Journal of Cardiology·A J CammC M Pratt
Aug 9, 2005·European Journal of Pharmacology·Joffrey DucroqJean-Louis Gérard
Jun 19, 2001·Current Cardiology Reports·B N Singh, J S Sarma
Mar 28, 2006·British Journal of Pharmacology·Petsy Pui-Sze SoPaul Dorian
Oct 16, 2004·Journal of Cardiovascular Electrophysiology·Peter SmetanaMarek Malik
Jun 26, 1998·Journal of Cardiovascular Pharmacology·G A Gintant
Aug 19, 2003·British Journal of Pharmacology·Anikó KovácsGábor Szénási
Aug 15, 2000·Journal of Cardiovascular Pharmacology·V Nand, S A Doggrell